Pfizer is finally closing the door on a long-running legal battle in the Nigerian state of Kano. The case goes back to a 1996 study of Pfizer’s drug Trovan, conducted during a meningitis outbreak. The company will underwrite $30 million in health-care initiatives in Kano, give the state $10 million for legal costs and pay as much as $35 million to participants in the study, according to a statement out today. As part of the deal, Pfizer “specifically denies any wrongdoing or liability,” the statement says. As we explained in an earlier post , the Nigerian

state of Kano accused the company of illegally conducting a study that resulted in the deaths of 11 children and injury to many more. The company has said in the past that the trial was conducted ethically and with the full knowledge of the Nigerian government, and that it saved lives. For more on the backstory, see this 2006 article from the Washington Post, which has written extensively on the subject. Map via CIA World Factbook

Read the original post:
For Up to $75 Million, Pfizer Puts Nigeria Lawsuit Behind It